Laser capture microdissection (LCM) is an efficient and precise method for obtaining pure cell populations or specific cells of interest from a given tissue sample. LCM has been applied to animal and human gastroenterology research in analyzing the protein, DNA and RNA from all organs of the gastrointestinal system. There are numerous potential applications for this technology in gastroenterology research including malignancies of the esophagus, stomach, colon, biliary tract and liver. This technology can also be used to study gastrointestinal infections, inflammatory bowel disease, pancreatitis, motility, malabsorption and radiation enteropathy. LCM has multiple advantages when compared to conventional methods of microdissection, and this technology can be exploited to identify precursors to disease, diagnostic biomarkers, and therapeutic interventions.
separated when the cap is removed 1 . (Fig. 1a, b ) Then the cells can be lifted in a microfuge tube containing an extraction solution. The DNA, RNA and proteins are not damaged in this process. Gene chip analysis of LCM crypt base epithelial cells was used to define molecular features shared by adult mouse gut epithelial progenitors 2 .
LCM in Gastrointestinal Cancer
LCM has been applied to the study of many gastrointestinal malignancies including the esophagus, stomach, colon and liver. Streitz et al 3 used LCM to investigate the protein expression in patients with high-grade dysplasia of the esophagus and esophageal adenocarcinoma that had undergone esophagectomy. Benign appearing Barrett epithelium (BE) cells, malignant BE and normal epithelium were analyzed and compared for protein expression. Using LCM and mass spectrometry, unique protein peaks (7350, 8446, 10850, 14693) were found in benign appearing BE that were biomarkers for malignant BE. This study demonstrated how LCM can be used to identify individuals who are at increased risk for malignant transformation to esophageal cancer.
Wu et al 4 used LCM and microarray analysis to study gastric cancer. They were able to distinguish malignant versus benign gastric epithelial cells with an accuracy of 99% using 504 gene profiles including Trefoil 1, 2 and 3. LCM has also been used to study colorectal cancer. Melle et al 5 used LCM and SDS PAGE to compare protein biomarkers in colorectal cancer cells to adenomas and normal adjacent mucosa. They showed that a biomarker known as heat shock protein 10 (HSP-10) was found to be elevated in colorectal tumors. Similarly, Korekane et al 6 studied protein expression in the tumor cells of the colonic epithelium. They compared the tumor cells to the normal adjacent epithelial cells in colectomy specimens and found different expression profiles of N-Glycans. Additionally, they noted that using LCM with a BCA protein assay was superior to reverse phase HPLC with mass spectrometry. Using LCM, they identified seven distinct N-Glycans in the tumor cells that would have otherwise been undetected using a conventional method.
Since epidermal growth factor receptor (EGFR) inhibitors have been shown to be effective in inhibiting some solid tumors, many studies have examined EGFR mutations as a target for inhibition. Leone et al 7 investigated patients with bile duct carcinoma (BDC) and gall bladder (GBC) cancer. Using LCM and gene amplification, they demonstrated that a subgroup of their patients had a mutation in the EGFR gene which is thought to influence tyrosine kinase activity and may be susceptible to targeted therapy with an EGFR inhibitor.
Recently, LCM was used to study Hepatocellular Carcinoma (HCC). Ieta et al 8 studied Ube2c expression in patients with HCC using LCM, RT-PCR, and microarray analysis. They found that the expression of Ube2c was increased in malignant hepatocytes compared to the normal hepatocytes. Elevated Ube2c expression was also found to be associated with increased tumor invasion into the portal vein and poor survival rates. This study demonstrates how LCM is used to identify biomarkers that can have prognostic value in patients with HCC. In addition, Honda et al 9 studied hepatoctyes from patients with chronic hepatitis B (CHB) and chronic hepatitis C (CHC) who had Hepatocellular Carcinoma (HCC). They utilized LCM and cDNA microarray technology. The investigators found that the CHB specimens had upregulation of genes related to pro-apoptotic activity and cell cycle arrest versus CHC specimens that had upregulation of genes related to anti-apoptosis and cell cycle acceleration. This study demonstrates how LCM can be used to understand the different mechanisms of malignant transformation to HCC.
LCM in Other Gastrointestinal Diseases
LCM has allowed investigators to study inflammatory bowel disease (IBD). Bowel flora has been implicated in the pathogenesis of Crohn's Disease (CD). De Hertogh et al 10 examined cells from the ileum, appendix and colon in patients with CD to study bacterial populations of the bowel flora. They used LCM and PCR amplification to show that Enterobacteraciae may be the initiating organism in CD related ulcers. Similarly, Ryan et al 11 examined the small and large bowel granulomas in patients with CD compared to patients with non-CD related granulomas. Using LCM and PCR amplification to analyze the bacterial DNA of the bowel flora, it was shown that Escherichia Coli DNA is more common in the CD granulomas than non-CD related granulomas. These studies demonstrate that LCM can be used successfully to analyze bowel flora in patients with Crohn's Disease.
Clostridium Difficile is a common cause of antibiotic induced diarrhea in animals and humans. Savidge et al 12 used LCM to study the enterotoxic effects of toxin B compared to toxin A. Fetal human xenografts of the colon were infected with C. Difficile toxin A or B and implanted into the ileum of scid mice. Using LCM to dissect the human colon cells and RT-PCR, this study showed that both toxins were associated with increased levels of interleukin-8 and an increased inflammatory response. Similarly, LCM can be used to study other bacteria such as Helicobacter Pylori. Resnick et al 13 examined the gastric epithelium from patients with peptic ulcer disease who had gastric biopsies before and after H. pylori eradication. The results showed that 9,680 mRNA transcripts increased and 13,817 decreased after eradication. This study shows how LCM was used to understand the epithelial transcriptome of the gastric antrum to target future research.
LCM can also be used to study the effects of therapeutic radiation on the intestines. Wang et al 14 used LCM to study the pathogenesis of radiation enteropathy. They examined the small bowel of rats after irradiation of their small intestine. They used LCM to microdissect smooth muscle cells from the distal ileum as well as reverse transcription PCR and found that endothelial thrombomodulin expression was decreased and protease activated receptor 1 levels were significantly increased. This demonstrates how LCM can be used to understand the pathogenesis of radiation induced damage of the gastrointestinal tract.
LCM can be used to investigate the pathophysiology of malabsorptive disorders. Gassler et al 15 studied patients with a history of adenocarcinoma of the colon who had undergone resection of their small intestine. They used LCM (Fig. 2) and microarray analysis to show the differential gene expression profiles of the villus and crypt enterocytes in the human small intestine. They demonstrated the differential gene expression of the non absorptive enterocytes in the upper crypt and the absorptive enterocytes in the mid-villus. This application of LCM may lead to targeted therapies for malabsorptive disorders like celiac disease. Similarly, LCM was used by Erwin et al 16 to examine the differential gene expression of crypt enterocytes in a murine model. (Fig. 3 ) This study demonstrated gut adaptation of the remnant small intestines following small bowel resection and changes in the genes that regulate cell growth. Using LCM, this study demonstrated how the differential gene expression of the crypt enterocyte adapts following small bowel resection. Epithelial barrier function of the small intestine is critical in protecting the interstitium from the harsh luminal environment. Tight junctions are an important component in this barrier function. Clayburgh et al 17 studied the expression of MLCK1 (long myosin light chain kinase splice variant 1)in the crypt-villus axis in the human jejunum. Using LCM they were able to isolate epithelial cells from the villus and crypt and demonstrate that MLCK1 expression was highest in the villus tip and regulated tight junction permeability.
Chronic pain is a predominant feature of chronic pancreatitis. Xu et al 18 have used LCM to explore the pathophysiology of chronic pain. They studied rats with chronic pancreatitis induced by trinitrobenzene sulfonic acid and the mRNA expression of transient receptor potential vanilloid 1 (TRPV1). LCM was used to isolate pancreas specific dorsal root ganglion cells. The mRNA expressed by TRPV1 was found to be increased in rats with chronic pancreatitis. Additionally, they showed that administering TRPV1 antagonists decreased visceral pain associated with chronic pancreatitis. This study demonstrates how LCM can be used to study therapeutic interventions in chronic pancreatitis.
Investigators have used LCM, to isolate cells from the myenteric plexus. Using LCM of the myenteric plexus and the villus epithelium in the jejunum, Guan et al 19 demonstrated that GLP2 stimulated vascular blood flow is mediated by vasoactive neurotransmitters that colocalize with GLP2 in two distinct cell types (neurons and villus epithelium) within the gastrointestinal tract.
Discussion
LCM is a major advance as a microdissection technique compared to previously existing methods, but some disadvantages exist. The equipment may be considered expensive, and a manual dissection may be more cost effective and yield a reliable result. One study showed that LCM may not be necessary to identify tumor cell-specific gene expression profiles, and the macrodissected samples yielded reliable data when compared to microdissected tissue. 20 There also may be technical difficulties in preparing the tissue, and adhering the tissue to the film may be challenging. In spite of the disadvantages, LCM has been proven to be an efficient method for obtaining pure populations of cells from a heterogeneous tissue sample. LCM has the potential to help us understand the pathogenesis of many diseases as well as help to target interventions for future drugs. Future applications of LCM may include isolating selected populations of tissue for cultivation, manipulation, and cloning. This would allow a larger population of cells for current and future experiments. It is clear that LCM is a significant advancement in microdissection technology. Combining LCM with common molecular analytic techniques has provided an exciting method to visualize, dissect and analyze cells of the gastrointestinal system with precision and efficiency. 
